Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-004786
Filing Date
2025-06-13
Accepted
2025-06-13 16:13:01
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4190
2 MBPOA mbablerpoa.txt EX-24 3982
  Complete submission text file 0001562180-25-004786.txt   9717
Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Babler Martin (Reporting) CIK: 0001435618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 251046693

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)